Stimulation of neoplastic mouse lung cell proliferation by alveolar macrophage-derived, insulin-like growth factor-1 can be blocked by inhibiting MEK and PI3K activation

<p>Abstract</p> <p>Background</p> <p>Worldwide, lung cancer kills more people than breast, colon and prostate cancer combined. Alterations in macrophage number and function during lung tumorigenesis suggest that these immune effector cells stimulate lung cancer growth....

Full description

Bibliographic Details
Main Authors: Malkinson Alvin M, Dwyer-Nield Lori D, Fritz Jason M
Format: Article
Language:English
Published: BMC 2011-06-01
Series:Molecular Cancer
Subjects:
Online Access:http://www.molecular-cancer.com/content/10/1/76
id doaj-7087df2b0cfb4211a4bb06355287783b
record_format Article
spelling doaj-7087df2b0cfb4211a4bb06355287783b2020-11-24T21:19:21ZengBMCMolecular Cancer1476-45982011-06-011017610.1186/1476-4598-10-76Stimulation of neoplastic mouse lung cell proliferation by alveolar macrophage-derived, insulin-like growth factor-1 can be blocked by inhibiting MEK and PI3K activationMalkinson Alvin MDwyer-Nield Lori DFritz Jason M<p>Abstract</p> <p>Background</p> <p>Worldwide, lung cancer kills more people than breast, colon and prostate cancer combined. Alterations in macrophage number and function during lung tumorigenesis suggest that these immune effector cells stimulate lung cancer growth. Evidence from cancer models in other tissues suggests that cancer cells actively recruit growth factor-producing macrophages through a reciprocal signaling pathway. While the levels of lung macrophages increase during tumor progression in mouse models of lung cancer, and high pulmonary macrophage content correlates with a poor prognosis in human non-small cell lung cancer, the specific role of alveolar macrophages in lung tumorigenesis is not clear.</p> <p>Methods</p> <p>After culturing either an immortalized lung macrophage cell line or primary murine alveolar macrophages from naïve and lung-tumor bearing mice with primary tumor isolates and immortalized cell lines, the effects on epithelial proliferation and cellular kinase activation were determined. Insulin-like growth factor-1 (IGF-1) was quantified by ELISA, and macrophage conditioned media IGF-1 levels manipulated by IL-4 treatment, immuno-depletion and siRNA transfection.</p> <p>Results</p> <p>Primary macrophages from both naïve and lung-tumor bearing mice stimulated epithelial cell proliferation. The lungs of tumor-bearing mice contained 3.5-times more IGF-1 than naïve littermates, and media conditioned by freshly isolated tumor-educated macrophages contained more IGF-1 than media conditioned by naïve macrophages; IL-4 stimulated IGF-1 production by both macrophage subsets. The ability of macrophage conditioned media to stimulate neoplastic proliferation correlated with media IGF-1 levels, and recombinant IGF-1 alone was sufficient to induce epithelial proliferation in all cell lines evaluated. Macrophage-conditioned media and IGF-1 stimulated lung tumor cell growth in an additive manner, while EGF had no effect. Macrophage-derived factors increased p-Erk1/2, p-Akt and cyclin D1 levels in neoplastic cells, and the combined inhibition of both MEK and PI3K ablated macrophage-mediated increases in epithelial growth.</p> <p>Conclusions</p> <p>Macrophages produce IGF-1 which directly stimulates neoplastic proliferation through Erk and Akt activation. This observation suggests that combining macrophage ablation therapy with IGF-1R, MEK and/or PI3K inhibition could improve therapeutic response in human lung cancer. Exploring macrophage-based intervention could be a fruitful avenue for future research.</p> http://www.molecular-cancer.com/content/10/1/76Lung cancermacrophagesproliferationIGF-1cytokines
collection DOAJ
language English
format Article
sources DOAJ
author Malkinson Alvin M
Dwyer-Nield Lori D
Fritz Jason M
spellingShingle Malkinson Alvin M
Dwyer-Nield Lori D
Fritz Jason M
Stimulation of neoplastic mouse lung cell proliferation by alveolar macrophage-derived, insulin-like growth factor-1 can be blocked by inhibiting MEK and PI3K activation
Molecular Cancer
Lung cancer
macrophages
proliferation
IGF-1
cytokines
author_facet Malkinson Alvin M
Dwyer-Nield Lori D
Fritz Jason M
author_sort Malkinson Alvin M
title Stimulation of neoplastic mouse lung cell proliferation by alveolar macrophage-derived, insulin-like growth factor-1 can be blocked by inhibiting MEK and PI3K activation
title_short Stimulation of neoplastic mouse lung cell proliferation by alveolar macrophage-derived, insulin-like growth factor-1 can be blocked by inhibiting MEK and PI3K activation
title_full Stimulation of neoplastic mouse lung cell proliferation by alveolar macrophage-derived, insulin-like growth factor-1 can be blocked by inhibiting MEK and PI3K activation
title_fullStr Stimulation of neoplastic mouse lung cell proliferation by alveolar macrophage-derived, insulin-like growth factor-1 can be blocked by inhibiting MEK and PI3K activation
title_full_unstemmed Stimulation of neoplastic mouse lung cell proliferation by alveolar macrophage-derived, insulin-like growth factor-1 can be blocked by inhibiting MEK and PI3K activation
title_sort stimulation of neoplastic mouse lung cell proliferation by alveolar macrophage-derived, insulin-like growth factor-1 can be blocked by inhibiting mek and pi3k activation
publisher BMC
series Molecular Cancer
issn 1476-4598
publishDate 2011-06-01
description <p>Abstract</p> <p>Background</p> <p>Worldwide, lung cancer kills more people than breast, colon and prostate cancer combined. Alterations in macrophage number and function during lung tumorigenesis suggest that these immune effector cells stimulate lung cancer growth. Evidence from cancer models in other tissues suggests that cancer cells actively recruit growth factor-producing macrophages through a reciprocal signaling pathway. While the levels of lung macrophages increase during tumor progression in mouse models of lung cancer, and high pulmonary macrophage content correlates with a poor prognosis in human non-small cell lung cancer, the specific role of alveolar macrophages in lung tumorigenesis is not clear.</p> <p>Methods</p> <p>After culturing either an immortalized lung macrophage cell line or primary murine alveolar macrophages from naïve and lung-tumor bearing mice with primary tumor isolates and immortalized cell lines, the effects on epithelial proliferation and cellular kinase activation were determined. Insulin-like growth factor-1 (IGF-1) was quantified by ELISA, and macrophage conditioned media IGF-1 levels manipulated by IL-4 treatment, immuno-depletion and siRNA transfection.</p> <p>Results</p> <p>Primary macrophages from both naïve and lung-tumor bearing mice stimulated epithelial cell proliferation. The lungs of tumor-bearing mice contained 3.5-times more IGF-1 than naïve littermates, and media conditioned by freshly isolated tumor-educated macrophages contained more IGF-1 than media conditioned by naïve macrophages; IL-4 stimulated IGF-1 production by both macrophage subsets. The ability of macrophage conditioned media to stimulate neoplastic proliferation correlated with media IGF-1 levels, and recombinant IGF-1 alone was sufficient to induce epithelial proliferation in all cell lines evaluated. Macrophage-conditioned media and IGF-1 stimulated lung tumor cell growth in an additive manner, while EGF had no effect. Macrophage-derived factors increased p-Erk1/2, p-Akt and cyclin D1 levels in neoplastic cells, and the combined inhibition of both MEK and PI3K ablated macrophage-mediated increases in epithelial growth.</p> <p>Conclusions</p> <p>Macrophages produce IGF-1 which directly stimulates neoplastic proliferation through Erk and Akt activation. This observation suggests that combining macrophage ablation therapy with IGF-1R, MEK and/or PI3K inhibition could improve therapeutic response in human lung cancer. Exploring macrophage-based intervention could be a fruitful avenue for future research.</p>
topic Lung cancer
macrophages
proliferation
IGF-1
cytokines
url http://www.molecular-cancer.com/content/10/1/76
work_keys_str_mv AT malkinsonalvinm stimulationofneoplasticmouselungcellproliferationbyalveolarmacrophagederivedinsulinlikegrowthfactor1canbeblockedbyinhibitingmekandpi3kactivation
AT dwyernieldlorid stimulationofneoplasticmouselungcellproliferationbyalveolarmacrophagederivedinsulinlikegrowthfactor1canbeblockedbyinhibitingmekandpi3kactivation
AT fritzjasonm stimulationofneoplasticmouselungcellproliferationbyalveolarmacrophagederivedinsulinlikegrowthfactor1canbeblockedbyinhibitingmekandpi3kactivation
_version_ 1726005793846722560